Newron Pharmaceuticals S.p.A., IT0004147952

Newron Pharmaceuticals S.p.A. / IT0004147952

18.06.2024 - 10:00:26

Newron Pharmaceuticals S.p.A.: Dr. Ulrich Köstlin, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

18.06.2024 / 09:59 CET/CEST
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Ulrich
Last name(s): Köstlin

2. Reason for the notification

a) Position / status
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Newron Pharmaceuticals S.p.A.

b) LEI

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: IT0004147952

b) Nature of the transaction

c) Price(s) and volume(s)
Price(s) Volume(s)
10.20 EUR 16044.6 EUR
10.20 EUR 10200 EUR

d) Aggregated information
Price Aggregated volume
10.2000 EUR 26244.6000 EUR

e) Date of the transaction
17/06/2024; UTC+2

f) Place of the transaction
Name: Xetra

18.06.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: Newron Pharmaceuticals S.p.A.
via Antonio Meucci 3
20091 Bresso

End of News EQS News Service

92489  18.06.2024 CET/CEST fncls.ssp?fn=show_t_gif&application_id=1927581&application_name=news&site_id=trading_house_net~~~7efceac5-959a-43d6-afef-21ad42b6a5d4